Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer’s disease

PURPOSE: Development of novel biomarkers for AD is important for early diagnosis, monitoring disease progression and therapeutic response. The aim of this study was to identify the potential CSF biomarkers for Alzheimer's disease (AD) and evaluate these markers on independent CSF samples using...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Proteomics Clin Appl
Asıl Yazarlar: Sathe, Gajanan, Na, Chan Hyun, Renuse, Santosh, Madugundu, Anil K., Albert, Marilyn, Moghekar, Abhay, Pandey, Akhilesh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6639119/
https://ncbi.nlm.nih.gov/pubmed/30578620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prca.201800105
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller